Defining Cancer Subtypes With Distinctive Etiologic Profiles: An Application to the Epidemiology of Melanoma

References

• Althuis, M. D., Fergenbaum, J. H., Garcia-Closas, M., Brinton, L. A., Madigan, M. P., and Sherman, M. E. (2004), “Etiology of Hormone Receptor-Defined Breast Cancer: A Systematic Review of the Literature,” Cancer Epidemiology, Biomarkers and Prevention, 13, 1558–1568.
   PubMed Web of Science ®Google Scholar
• Bauer, J., Büttner, P., Murali, R., Okamoto, I., Kolaitis, N. A., Landi, M. T., Scolyer, R. A., and Bastian, B. C. (2011), “BRAF Mutations in Cutaneous Melanoma are Independently Associated with Age, Anatomic Site of the Primary Tumor, and the Degree of Solar Elastosis at the Primary Tumor Site,” Pigment Cell and Melanoma Research, 24(2), 345–351.
   PubMed Web of Science ®Google Scholar
• Begg, C. B. (2011), “A Strategy for Distinguishing Optimal Cancer Subtypes,” International Journal of Cancer, 129, 931–937.
   PubMed Web of Science ®Google Scholar
• Begg, C. B., and Gray, R. J. (1984), “Calculation of Polychotomous Logistic Regression Parameters using Individualized Regressions,” Biometrika 1984, 71, 11–18.
   Google Scholar
• Begg, C. B., Hummer, A. J., Mujumdar, U., Armstrong, B. K., Kricker, A., Marrett, L. D., Millikan, R. C., Gruber, S. B., Culver, H. A., Zanetti, R., Gallagher, R. P., Dwyer, T., Rebbeck, T. R., Busam, K., From, L., and Berwick, M. (2006), “A Design for Cancer Case-Control Studies using only Incident Cases: Experience with the GEM Study of Melanoma,” International Journal of Epidemiology, 35, 756–764.
   PubMed Web of Science ®Google Scholar
• Begg, C. B., Orlow, I., Zabor, E. C., Arora, A., Sharma, A., Seshan, V. E., and Bernstein, J. L. (2015), “Identifying Etiologically Distinct Subtypes of Cancer: A Demonstration Project Involving Breast Cancer,” Cancer Medicine, 4, 1432–1439.
   PubMed Web of Science ®Google Scholar
• Begg, C. B., and Zabor, E. C. (2012), “Detecting and Exploiting Etiologic Heterogeneity in Epidemiologic Studies,” American Journal of Epidemiology, 176, 512–518.
   PubMed Web of Science ®Google Scholar
• Begg, C. B., Zabor, E. C., Bernstein, J. L., Bernstein, L., Press, M. F., Seshan, and V. E. (2013), “A Conceptual and Methodological Framework for Investigating Etiologic Heterogeneity,” Statistics in Medicine, 32, 5039–5052.
   PubMed Web of Science ®Google Scholar
• Begg, C. B., and Zhang, Z. F. (1994), “Statistical Analysis of Molecular Epidemiology Studies Employing Case-Series,” Cancer Epidemiology, Biomarkers and Prevention, 3, 173–175.
   PubMed Web of Science ®Google Scholar
• Calinski, T., and Harabasz, J. (1974), “A Dendrite Method for Cluster Analysis,” Communications in Statistics, 3, 1–27.
   Google Scholar
• Chatterjee, N. (2004), “A Two-Stage Regression Model for Epidemiological Studies with Multivariate Disease Classification Data,” Journal of the American Statistical Association, 99, 127–138.
   Web of Science ®Google Scholar
• Cho, E., Rosner, B. A., and Colditz, G. A. (2005), “Risk Factors for Melanoma by Body Site,” Cancer Epidemiology, Biomarkers and Prevention, 14, 1241–1244.
   PubMed Web of Science ®Google Scholar
• Dubin, N., and Pasternak, B. S. (1986), “Risk Assessment for Case–Control Subgroups by Polychotomous Logistic Regression,” American Journal of Epidemiology, 123, 1101–1117.
   PubMed Web of Science ®Google Scholar
• Hartigan, J. A., and Wong, M. A. (1979), “A K-Means Clustering Algorithm,” Applied Statistics, 28, 100–108.
   Google Scholar
• Gibbs, D. C., Orlow, I., Kanetsky, P. A., Luo, L., Kricker, A., Armstrong, B. K., Anton-Culver, H., Gruber, S. B., Marrett, L. D., Gallagher, R. P., Zanetti, R., Rosso, S., Dwyer, T., Sharma, A., La Pilla, E., From, L., Busam, K. J., Cust, A. E., Ollila, D. W., Begg, C. B., Berwick, M., and Thomas, N. E., on behalf of the GEM Study Group (2015), “Inherited Genetic Variants Associated with Occurrence of Multiple Primary Melanoma,” Cancer Epidemiology, Biomarkers and Prevention, 24, 992–997.
   PubMed Web of Science ®Google Scholar
• Gibbs, D. C., Orlow, I., Bramson, J. I., Kanetsky, P. A., Luo, L., Kricker, A., Armstrong, B. K., Anton-Culver, H., Gruber, S. B., Marrett, L. D., Gallagher, R. P., Zanetti, R., Rosso, S., Dwyer, T., Sharma, A., La Pilla, E., From, L., Busam, K. J., Cust, A. E., Ollila, D. W., Begg, C. B., Berwick, M., and Thomas, N. E., on behalf of the GEM Study Group (2016), “Association of Interferon Regulatory Factor-4 (IRF4) Polymorphism rs12203592 with Divergent Melanoma Pathways,” Journal of the National Cancer Institute, 108, djw004.
   PubMedGoogle Scholar
• Jaeger, M. (2006), “On Testing the Missing at Random Assumption,” in Machine Learning: ECML 2006, eds. J. Fürnkranz, T. Scheffer, and M. Spiliopoulou, Lecture Notes in Computer Science. Berlin: Springer, pp. 671–78.
   Google Scholar
• Marshall, A., Altman, D. G., Holder, R. L., and Royston, P. (2009), “Combining Estimates of Interest in Prognostic Modeling Studies After Multiple Imputation: Current Practice and Guidelines,” BMC Medical Research Methodology, 9, 57.
   PubMed Web of Science ®Google Scholar
• Nielsen, K., Masback, A., Olsson, H., and Ingvar, C. (2012), “A Prospective, Population-based Study of 40,000 Women Regarding Host Factors, UV Exposure and Sunbed use in Relation to Risk and Anatomic Site of Cutaneous Melanoma,” International Journal of Cancer, 131, 706–715.
   PubMed Web of Science ®Google Scholar
• Potthoff, R. F., Tudor, G. E., Tudor, K., Pieper, S., and Hasselblad, V. (2006), “Can One Assess Whether Missing Data are Missing at Random in Medical Studies?,” Statistical Methods in Medical Research, 15, 213–234. doi:10.1191/0962280206sm448oa.
   PubMed Web of Science ®Google Scholar
• Rosner, B., Glynn, R. J., Tamimi, R. M., Chen, W. Y., Colditz, G. A., Willett, W. C., and Hankinson, S. E. (2013), “Breast Cancer Risk Prediction with Heterogeneous Risk Profiles According to Breast Cancer Tumor Markers,” American Journal of Epidemiology, 178, 296–308.
   PubMed Web of Science ®Google Scholar
• Rubin, D. B. (1996), “Multiple Imputation after 18+ Years,” Journal of the American Statistical Association, 91, 473–489.
   Web of Science ®Google Scholar
• Thomas, N. E., Edmiston, S. N., Alexander, A., Millikan, R. C., Groben, P. A., Hao, H., Tolbert, D., Berwick, M., Busam, K., Begg, C. B., Mattingly, D., Ollila, D. W., Tse, C. K., Hummer, A., Lee-Taylor, J., and Conway, K. (2007), “Number of Nevi and Early-Life Ambient UV Exposure are Associated with BRAF-Mutant Melanoma,” Cancer Epidemiology, Biomarkers and Prevention, 16, 991–997.
   PubMed Web of Science ®Google Scholar
• Thomas, N. E., Kanetsky, P. A., Edmiston, S. N., Alexander, A., Begg, C. B., Groben, P. A., Hao, H., Busam, K., Ollila, D. W., Berwick, M., and Conway, K. (2010), “Relationship between Germline MC1R Variants and BRAF-Mutant Melanoma in a North Carolina Population-Based Study,” Journal of Investigative Dermatology, 130, 1463–1465.
   PubMed Web of Science ®Google Scholar
• Thomas, N. E., Edmiston, S. N., Alexander, A., Groben, P. A., Parrish, E., Kricker, A., Armstrong, B. K., Anton-Culver, H., Gruber, S. B., From, L., Busam, K. J., Hao, H., Orlow, I., Kanetsky, P. A., Luo, L., Reiner, A. S., Paine, S., Frank, J. S., Bramson, J. I., Marrett, L. D., Gallagher, R. P., Zanetti, R., Rosso, S., Dwyer, T., Cust, A. E., Ollila, D. W., Begg, C. B., Berwick, M., and Conway, K., for The GEM Study Group (2015), “Association between NRAS and BRAF Mutational Status and Melanoma-Specific Survival among Patients with Higher Risk Primary Melanoma: A Population-Based Study,” JAMA Oncology, 1, 359–368.
   PubMed Web of Science ®Google Scholar
• Tibshirani, R., Walther, G., and Hastie, T. (2001), “Estimating the Number of Clusters in a Dataset via the Gap Statistic,” Journal of the Royal Statistical Society, Series B, 63, 411–423.
   Google Scholar
• van Buuren, S. (2007), “Multiple Imputation of Discrete and Continuous Data by Fully Conditional Specification,” Statistical Methods in Medical Research, 16, 219–242.
   PubMed Web of Science ®Google Scholar
• van Buuren, S., and Groothuis-Oudshoorn, K. (2011), “Mice: Multivariate Imputation by Chained Equations in R,” Journal of Statistical Software, 45.
   PubMed Web of Science ®Google Scholar
• Wang, M., Kuchiba, A., and Ogino, S. (2015), “A Meta-Regression Method for Studying Etiologic Heterogeneity Across Disease Subtypes Classified by Multiple Biomarkers,” American Journal of Epidemiology, 182, 263–270.
   PubMed Web of Science ®Google Scholar
• Wu, S., Kuo, H., Li, W. Q., Canales, A. L., Han, J., and Qureshi, A. A. (2014), “Association between BRAFV600E and NRASQ61R Mutations and Clinicopathologic Characteristics, Risk Factors and Clinical Outcome of Primary Invasive Cutaneous Melanoma,” Cancer Causes and Control, 25, 1379–1386.
   PubMed Web of Science ®Google Scholar
• Xue, X., Kim, M. Y., Gaudet, M. M., Park, Y., Heo, M., Hollenbeck, A. R., Strickler, H. D., and Gunter, M. J. (2013), “A Comparison of the Polytomous Logistic Regression and Joint Cox Proportional Hazards Models for Evaluating Multiple Disease Subtypes in Prospective Cohort Studies,” Cancer Epidemiology, Biomarkers and Prevention, 22, 275–285.
   PubMed Web of Science ®Google Scholar
• Yu, K., Zhang, H., Wheeler, W., Horne, H. N., Chen, J., and Figueroa, J. D. (2015), “A Robust Association Test for Detecting Genetic Variants with Heterogeneous Effects,” Biostatistics, 16, 5–16.
   PubMed Web of Science ®Google Scholar